Compare OEC & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OEC | CLPT |
|---|---|---|
| Founded | 1862 | 1998 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.0M | 467.9M |
| IPO Year | 2014 | 2009 |
| Metric | OEC | CLPT |
|---|---|---|
| Price | $5.73 | $13.76 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.56 | ★ $20.00 |
| AVG Volume (30 Days) | 362.7K | ★ 543.7K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,806,700,000.00 | $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | $2.21 | $19.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $4.35 | $8.27 |
| 52 Week High | $8.64 | $30.10 |
| Indicator | OEC | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 42.85 |
| Support Level | $5.61 | $13.42 |
| Resistance Level | $6.57 | $15.29 |
| Average True Range (ATR) | 0.29 | 0.61 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 14.94 | 25.25 |
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.